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Diso reconstruction especially featured for step-and-shoot IMRT was 
implemented using a set of simulated IMRT beams. These beams were 
parameterized by means of a fluence inhomogeneity index, FI, 
introduced to describe the degree of beam modulation as respect to 
open beams. All the dosimetric parameters involved in the Diso 
reconstruction algorithm, such as the correlation functions, the 
correction factor for scattered contribution due to different EPID to 
phantom distances and the modulated tissue maximum ratios were 
measured taking into account the FI index. 20 clinical IMRT beams 
were tested and used to irradiate a homogeneous phantom; 100 IVD 
were reconstructed in 5 different geometrical set-up. In addition, the 
dedicated software supplied for each beam the γ-analysis of the 2D 
comparison between portal images to test the beam irradiation 
reproducibility. 
Results: 55 simulated IMRT beams, with FI index ranging from 0.5 to 
6, were used to generalize the IVD algorithm to step-and-shoot IMRT. 
Each of the 100 clinical tests (5 tests per beam) showed an agreement 
between the in-vivo dose, Diso, and the TPS dose, Diso,TPS, within 
5%. The agreement was better than 4% when the comparison was 
carried out between the averaged isocenter doses from all beams of 
each treatment. For all beams, the γ-analysis between subsequent 
portal images was within the tolerance levels (3%/3mm), supplying a 
γmean < 0.3 and a pass-rate Pγ<1 >96%. The results are supplied in 
quasi real-time: after only 2 minutes from the end overall plan 
delivery the IVD test for all beams are performed and displayed. 
Conclusions: The IVD procedure here presented is one of the goals of 
an Italian Project supported by the Istituto Nazionale di Fisica 
Nucleare (INFN). The results of this study confirm that it’s possible (i) 
to reach the accuracy of 5% for the IVD Diso test also for IMRT 
treatments and (ii) to obtain the IVD results in a quasi real time at the 
end of the treatment delivery. In addition, we remark that our IVD 
procedure needs an easy commissioning for all Elekta linacs equipped 
with IviewGT aSi-EPID.  
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Purpose/Objective: In small fields dosimetry the measurement of 
output factors (OF) is affected by detectors effects, as the volume 
averaging effect for ionization chambers or higher scatter due to the 
presence of high Z material for diodes; the use of correction factors to 
the experimental measurements is therefore necessary for accurate 
results. For the Cyberknife system the correcting factors from Monte 
Carlo simulations, for several active dosimeters, have been recently 
published. The radiochromic films, characterized by high spatial 
resolution and water equivalence, could be considered an 'effects free 
detector', thus a valid alternative approach. Aim of this work is the 
measurement of OF with radiochromic films for small fields on a 
Cyberknife unit. 
Materials and Methods: EBT3 radiochromic films (batch #A04031201) 
were used to measure the output factor (OF), hereinafter referred to 
as OFgaf, in solid water at 15mm depth, at 800mm reference source-
to-distance detector (SDD) on a Cyberknife® system (6MV, 800mu min-
1) for fixed collimators with diameters ranging from 5mm to 25mm. 
During the system's commissioning the OF were measured at same 
depth and SDD in water phantom with a stereotactic diode (PTW 
model 60017), hereinafter referred to as OFdiode. For each fixed 
collimator 3 precut films were irradiated at a nominal dose of 400cGy: 
the necessary MU to obtain a nominal dose of 400cGy were calculating 
starting from the OFdiode. After 24 hours from the irradiation the films 
were acquired with a flatbed scanner (Epson V750pro) in transmission 
mode, 48 bit color, 150 dpi resolution. A dose calibration curve was 
obtained for the same batch. The green channel response were 
considered. For each field the OFgaf is calculated as the ratio between 
the measured dose per MU normalized to the measured dose per MU of 
the 60mm collimator. The mean dose was evaluated with two circular 
ROIs with diameter equal to 0.5mm (ROIA) and of 1.2mm (ROIB), 
centered on the field's centroid. The field's centroid were estimated 
with an automatic growing tools on the thresholded image. The 
analysis of the films were performed in ImageJ® with an automatic 
plugin. The results from both ROIs were compared to OFdiode. 
Results: With ROIA the percentage difference between the OFgaf and 
OFdiode ranges from -4.5% to -1.7%, with ROIB the percentage 
difference ranges from -5.4% to -1.4% for collimator from 5mm to 
12.5mm; for the other collimators the differences are negligible. 
Applying the Monte Carlo correction factors to the commissioning data 
the difference for the smallest collimator decrease to -0.1% and -1.1% 
for ROIA and ROIB respectively. 
Conclusions: The radiochromic films results have shown good 
agreement with the commissioning data, once the Monte Carlo 
correction have been applied. Moreover the results agree with the 
diodes' data for collimators larger than 12.5mm, for which the Monte 
Carlo corrections are negligible. The use of radiochromic films for 
estimating the output factors could be suggested as a valid 
comparison method for a Cyberknife® system.  
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Purpose/Objective: To demonstrate that precise skin dose 
measurement is possible with EBT2 films. 
Materials and Methods: A post-mastectomy breast cancer patient was 
followed with in vivo dosimetry during the full course of radiation 
treatment. Treatment consisted of 50Gy/25fx to the whole chestwall 
and supraclavicular region, followed with a boost of 10Gy/5fx to the 
surgery scar. The patient was treated on the TomoTherapy Hi-Art II 
system using a 4-field TomoDirect treatment for the chestwall and a 
TomoHelical treatment for the boost. The boost was planned and 
treated with a 0.5cm bolus covering the mastectomy scar. Gafchromic 
EBT2 films were cut to square pieces of ~1-2mm. A 5-film sample was 
placed at each of the medial and lateral scar extremities. The film 
pieces were affixed to the patient’s skin using surgical tape. Film 




Results: One measurement from the chestwall treatment was not 
included in analysis due to scanner error. For the chestwall 
treatment, the medial mean dose measured 106.9cGy (σ=3.7cGy) 
while the lateral mean dose measured 127.6cGy (σ=5.5cGy). For the 
boost treatment, the medial mean dose measured 197.9cGy 
(σ=6.4cGy) while the lateral mean dose measured 187.8cGy 
(σ=5.9cGy). The STDs in measured dose observed for the boost 
treatment positions are decreased to 1.7cGy and 3.1cGy respectively 
with the exclusion of one fraction from the data set.  
Conclusions: Intrinsic error due to the film and dosimetry method is 
estimated at 1.4cGy, therefore points outside of ±3σ (4.2cGy) are 
significant.1 Though, uncertainty in film placement on the patient is 
included in the measurements and must be taken into account when 
scrutinizing these results. The STD in dose measurements was 
noticeably larger for the lateral position compared to the medial 
position. This result is hypothesized to be due to variability in 
ipsilateral axillar repositioning we’ve observed in breast patients. 
Accuracy of the film measurements with respect to the TPS 
calculation was not a goal of the study. The depth of measurement of 
EBT2 films is approx. 0.1mm and therefore skin dose measurement 
comparison to calculation is premature due to voxel size dose 
averaging and TPS calculation uncertainties in the buildup region. Yet, 
all boost measurements, with exemption to one fraction, showed very 
good agreement with the calculation. This result can be explained 
because of the use of a 0.5cm bolus in the boost plan and the skin’s 
inclusion within the PTV, thereby avoiding the voxel averaging and 
TPS uncertainties observed in the buildup region. The outlying boost 
result could be due to an error in the film’s placement. A 4mm 
displacement, i.e. 2-pixel shift in calculation, on the skin correlates 
with a decrease of 20cGy in calculated dose due to the high gradient 
in the boost plan.  
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